SEARCH

SEARCH BY CITATION

References

  • 1
    Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008; 8: 96775.
  • 2
    Morriss GM, New DA. Effect of oxygen concentration on morphogenesis of cranial neural folds and neural crest in cultured rat embryos. J Embryol Exp Morphol. 1979; 54: 1735.
  • 3
    Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270: 12307.
  • 4
    Mitchell JA, Yochim JM. Intrauterine oxygen tension during the estrous cycle in the rat: its relation to uterine respiration and vascular activity. Endocrinology. 1968; 83: 7015.
  • 5
    Rodesch F, Simon P, Donner C, et al . Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992; 80: 2835.
  • 6
    Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998; 17: 300515.
  • 7
    Iyer NV, Kotch LE, Agani F, et al . Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998; 12: 14962.
  • 8
    Maltepe E, Schmidt JV, Baunoch D, et al . Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 1997; 386: 4037.
  • 9
    Peng J, Zhang L, Drysdale L, et al . The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA. 2000; 97: 838691.
  • 10
    Compernolle V, Brusselmans K, Acker T, et al . Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002; 8: 70210.
  • 11
    Scortegagna M, Ding K, Oktay Y, et al . Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet. 2003; 35: 33140.
  • 12
    Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002; 2: 3847.
  • 13
    Studer L, Csete M, Lee SH, et al . Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000; 20: 737783.
  • 14
    Morrison SJ, Csete M, Groves AK, et al . Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci. 2000; 20: 73706.
  • 15
    Schipani E, Ryan HE, Didrickson S, et al . Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 2001; 15: 286576.
  • 16
    Yun Z, Maecker HL, Johnson RS, et al . Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell. 2002; 2: 33141.
  • 17
    Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978; 4: 725.
  • 18
    Song X, Zhu CH, Doan C, et al . Germline stem cells anchored by adherens junctions in the Drosophila ovary niches. Science. 2002; 296: 18557.
  • 19
    Yamashita YM, Jones DL, Fuller MT. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science. 2003; 301: 154750.
  • 20
    Yamashita YM, Mahowald AP, Perlin JR, et al . Asymmetric inheritance of mother versus daughter centrosome in stem cell division. Science. 2007; 315: 51821.
  • 21
    Goldstein B, Hird SN. Specification of the anteroposterior axis in Caenorhabditis elegans. Development. 1996; 122: 146774.
  • 22
    Siegrist SE, Doe CQ. Extrinsic cues orient the cell division axis in Drosophila embryonic neuroblasts. Development. 2006; 133: 52936.
  • 23
    Seydoux G, Braun RE. Pathway to totipotency: lessons from germ cells. Cell. 2006; 127: 891904.
  • 24
    Ghazizadeh S, Taichman LB. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J. 2001; 20: 121522.
  • 25
    Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 2006; 126: 145968.
  • 26
    Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006; 22: 33973.
  • 27
    Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol. 2004; 20: 695723.
  • 28
    Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol. 2006; 7: 3337.
  • 29
    Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008; 132: 63144.
  • 30
    Lim DA, Huang YC, Alvarez-Buylla A. The adult neural stem cell niche: lessons for future neural cell replacement strategies. Neurosurg Clin N Am. 2007; 18: 8192.
  • 31
    Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol. 2006; 18: 7049.
  • 32
    Ootani A, Li X, Sangiorgi E, et al . Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat Med. 2009; 15: 7016.
  • 33
    Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009; 10: 20717.
  • 34
    Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005; 434: 84350.
  • 35
    Fre S, Vignjevic D, Schoumacher M, et al . Epithelial morphogenesis and intestinal cancer: new insights in signaling mechanisms. Adv Cancer Res. 2008; 100: 85111.
  • 36
    Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood. 1993; 82: 20317.
  • 37
    Kiel MJ, Yilmaz OH, Iwashita T, et al . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121: 110921.
  • 38
    Kiel MJ, Yilmaz OH, Morrison SJ. CD150- cells are transiently reconstituting multipotent progenitors with little or no stem cell activity. Blood. 2008; 111: 44134.
  • 39
    BI L. The architecture of bone marrow cell populations. Dayton : OH; 1992.
  • 40
    Chow DC, Wenning LA, Miller WM, et al . Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J. 2001; 81: 68596.
  • 41
    Parmar K, Mauch P, Vergilio JA, et al . Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007; 104: 54316.
  • 42
    Danet GH, Pan Y, Luongo JL, et al . Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest. 2003; 112: 12635.
  • 43
    Adelman DM, Maltepe E, Simon MC. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev. 1999; 13: 247883.
  • 44
    Ramirez-Bergeron DL, Simon MC. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells. 2001; 19: 27986.
  • 45
    Genbacev O, Zhou Y, Ludlow JW, et al . Regulation of human placental development by oxygen tension. Science. 1997; 277: 166972.
  • 46
    Koay EJ, Athanasiou KA. Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis Cartilage. 2008; 16: 14506.
  • 47
    Jogi A, Ora I, Nilsson H, et al . Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA. 2002; 99: 70216.
  • 48
    Helczynska K, Kronblad A, Jogi A, et al . Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 2003; 63: 14414.
  • 49
    Caniggia I, Mostachfi H, Winter J, et al . Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest. 2000; 105: 57787.
  • 50
    Cowden Dahl KD, Fryer BH, Mack FA, et al . Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol Cell Biol. 2005; 25: 1047991.
  • 51
    Adelman DM, Gertsenstein M, Nagy A, et al . Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 2000; 14: 3191203.
  • 52
    Cowden Dahl KD, Robertson SE, Weaver VM, et al . Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol Biol Cell. 2005; 16: 190112.
  • 53
    Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129: 46572.
  • 54
    Hu CJ, Wang LY, Chodosh LA, et al . Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003; 23: 936174.
  • 55
    Gustafsson MV, Zheng X, Pereira T, et al . Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005; 9: 61728.
  • 56
    Covello KL, Kehler J, Yu H, et al . HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006; 20: 55770.
  • 57
    Gordan JD, Bertout JA, Hu CJ, et al . HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007; 11: 33547.
  • 58
    Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol. 2007; 9: 2107.
  • 59
    Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006; 7: 67889.
  • 60
    Dahlqvist C, Blokzijl A, Chapman G, et al . Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development. 2003; 130: 608999.
  • 61
    Blokzijl A, Dahlqvist C, Reissmann E, et al . Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol. 2003; 163: 7238.
  • 62
    Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006; 580: 28608.
  • 63
    Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol. 2004; 11: 42633.
  • 64
    Morrison SJ, Perez SE, Qiao Z, et al . Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 2000; 101: 499510.
  • 65
    Taylor MK, Yeager K, Morrison SJ. Physiological Notch signaling promotes gliogenesis in the developing peripheral and central nervous systems. Development. 2007; 134: 243547.
  • 66
    Harvey AJ, Kind KL, Pantaleon M, et al . Oxygen-regulated gene expression in bovine blastocysts. Biol Reprod. 2004; 71: 110819.
  • 67
    Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA. 2005; 102: 47838.
  • 68
    Covello KL, Simon MC, Keith B. Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Cancer Res. 2005; 65: 227786.
  • 69
    Boyer LA, Lee TI, Cole MF, et al . Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122: 94756.
  • 70
    Loh YH, Wu Q, Chew JL, et al . The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006; 38: 43140.
  • 71
    Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000; 24: 3726.
  • 72
    Tai MH, Chang CC, Kiupel M, et al . Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005; 26: 495502.
  • 73
    Kehler J, Tolkunova E, Koschorz B, et al . Oct4 is required for primordial germ cell survival. EMBO Rep. 2004; 5: 107883.
  • 74
    Korinek V, Barker N, Morin PJ, et al . Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997; 275: 17847.
  • 75
    Reya T, Duncan AW, Ailles L, et al . A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003; 423: 40914.
  • 76
    De Lau W, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci. 2007; 12: 47191.
  • 77
    Vaupel P. Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol. 1996; 388: 34151.
  • 78
    Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003; 9: 67784.
  • 79
    Axelson H, Fredlund E, Ovenberger M, et al . Hypoxia-induced dedifferentiation of tumor cells–a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol. 2005; 16: 55463.
  • 80
    Chen Y, De Marco MA, Graziani I, et al . Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 2007; 67: 79549.
  • 81
    Bedogni B, Warneke JA, Nickoloff BJ, et al . Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest. 2008; 118: 366070.
  • 82
    Sahlgren C, Gustafsson MV, Jin S, et al . Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA. 2008; 105: 63927.
  • 83
    Bertout JA, Patel SA, Fryer BH, et al . Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Res. 2009; 69: 321320.
  • 84
    Malanchi I, Peinado H, Kassen D, et al . Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008; 452: 6503.
  • 85
    Gordan JD, Simon MC. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev. 2007; 17: 717.
  • 86
    Dang CV, Kim JW, Gao P, et al . The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008; 8: 516.
  • 87
    Koshiji M, Kageyama Y, Pete EA, et al . HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004; 23: 194956.
  • 88
    Robey IF, Stephen RM, Brown KS, et al . Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia. 2008; 10: 74556.
  • 89
    Zhang J, Sattler M, Tonon G, et al . Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma. Cancer Res. 2009; 69: 508290.
  • 90
    Scortegagna M, Martin RJ, Kladney RD, et al . Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 2009; 69: 263846.
  • 91
    Dang CV, Lewis BC, Dolde C, et al . Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J Bioenerg Biomembr. 1997; 29: 34554.
  • 92
    Zhang H, Gao P, Fukuda R, et al . HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 2007; 11: 40720.
  • 93
    Li F, Wang Y, Zeller KI, et al . Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol. 2005; 25: 622534.
  • 94
    Raval RR, Lau KW, Tran MG, et al . Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005; 25: 567586.
  • 95
    Gordan JD, Lal P, Dondeti VR, et al . HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell. 2008; 14: 43546.
  • 96
    An WG, Kanekal M, Simon MC, et al . Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 1998; 392: 4058.
  • 97
    Sanchez-Puig N, Veprintsev DB, Fersht AR. Binding of natively unfolded HIF-1alpha ODD domain to p53. Mol Cell. 2005; 17: 1121.
  • 98
    Ravi R, Mookerjee B, Bhujwalla ZM, et al . Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000; 14: 3444.
  • 99
    Moeller BJ, Dreher MR, Rabbani ZN, et al . Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell. 2005; 8: 99110.
  • 100
    Bertout JA, Majmundar AJ, Gordan JD, et al . HIF2{alpha} inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA. 2009; 106: 143916.
  • 101
    Moeller BJ, Cao Y, Li CY, et al . Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell. 2004; 5: 42941.